West Milford, NJ, United States of America

Rolf Wagner


Average Co-Inventor Count = 4.4

ph-index = 4

Forward Citations = 42(Granted Patents)


Location History:

  • Waukegan, IL (US) (1992)
  • West Milford, NJ (US) (1993 - 1996)

Company Filing History:


Years Active: 1992-1996

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Rolf Wagner: Pioneering Peptide Analogs for Appetite Suppression

Introduction

Rolf Wagner is an inventive mind located in West Milford, NJ, USA. He holds four patents to his name, each contributing significant advancements in the field of biochemistry and medicinal applications. His focus on peptide analogs reflects his commitment to innovation that addresses real-world challenges, particularly in appetite control.

Latest Patents

Wagner's latest patents include innovative approaches to appetite suppression through novel compounds. His patent titled "Analogs of Tyrosine Sulfate or Tyrosine Phosphate containing peptides" introduces new intermediate compounds that facilitate the preparation of these analogs. This innovative method aims to administer effective amounts of Cholecystokinin (CCK) analogs to subjects, which can significantly impact appetite management by substituting one or more Tyrosine Sulfate residues with unique radicals from his invention.

A related patent discusses "Intermediates for analogs of tyrosine sulfate or tyrosine phosphate," reiterating the importance of these compounds in the preparation of peptide analogs and further delving into methods to suppress appetite through effective clinical applications.

Career Highlights

Wagner's career is marked by his association with Hoffmann-La Roche Inc., a leading company in pharmaceutical innovation. His work has paved the way for potential breakthroughs in obesity treatment and metabolic regulation through peptide-based therapies.

Collaborations

Throughout his career, Rolf Wagner has collaborated with talented colleagues such as Waleed Danho and Jefferson Wright Tilley. Their combined expertise represents a powerful synergy that fosters creativity and innovation in developing new drug solutions.

Conclusion

Rolf Wagner stands out among inventors with his significant contributions to peptide research aimed at appetite suppression. His patents not only reveal the depth of his scientific inquiry but also show a dedication to improving health outcomes. As he continues to refine and expand upon his innovations, the implications of his work could have lasting impacts on the fields of biochemistry and health sciences.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…